PCM
ELV icon

Parsifal Capital Management’s Elevance Health ELV Stock Holding History

Parsifal Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-80,389
Closed -$43.6M – 17
2024
Q2 		$43.6M Sell
80,389
-6,719
-8% -$3.55M 3.14% 16
2024
Q1 		$45.2M Sell
87,108
-6,392
-7% -$3.18M 3.12% 13
2023
Q4 		$44.1M Sell
93,500
-6,000
-6% -$2.77M 3.03% 15
2023
Q3 		$43.3M Buy
+99,500
New +$45.1M 2.54% 16
2020
Q1 		– Sell
-35,000
Closed -$10.6M – 16
2019
Q4 		$10.6M Buy
+35,000
New +$9.63M 2.63% 11

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Parsifal Capital Management's ELV Position: Q3 2024 in Review

Parsifal Capital Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 80,389 shares — an estimated $43.6M sold.

Parsifal Capital Management first reported a position in ELV in Q4 2019 and held it in 5 quarters. The position peaked at $45.2M in Q1 2024. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Parsifal Capital Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Parsifal Capital Management sold 80,389 Elevance Health shares in Q3 2024, an estimated $43.6M.
  • Parsifal Capital Management first reported a position in Elevance Health in Q4 2019 and held it in 5 quarters.
  • Parsifal Capital Management's Elevance Health position peaked at $45.2M in Q1 2024.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Parsifal Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.